TITLE:
Metabolic Syndrome in the Internal Medicine Department of Chu Point G
AUTHORS:
Djenebou Traoré, Sy Djibril, Nongoba Sawadogo, Djeneba Sylla Sow, Massama Konaté, Nounga Romuald Nyanke, Ayayi Edem D’Almeida, Kaly Keita, Sekou Landouré, Nouhoum Koné, Moussa Sangaré, Mamadou Mallé, Ibrahima Amadou Dembélé, Mamadou Cissoko, Yacouba Koné, Aoua Diarra, Assetou Kaya Soukho
KEYWORDS:
Metabolic Syndrome, CHU Point G, Internal Medicine
JOURNAL NAME:
Open Journal of Internal Medicine,
Vol.13 No.3,
August
15,
2023
ABSTRACT: Introduction: The metabolic syndrome according to the IDF (International Diabetes Federation) is at the origin of the double global epidemic of type 2 diabetes and cardiovascular diseases. This work aims to study the metabolic syndrome in the internal medicine department of CHU Point G. Methodology: This was a descriptive study of patients who presented a metabolic syndrome according to the definition of the IDF definition, hospitalized in the internal medicine department of the CHU du point G for the period from January 1 2010 to December 31, 2019. Results: During the study period, 4189 patients were hospitalized, including 60 with metabolic syndrome, representing a hospital frequency of 1.43%. The sex ratio was 0.36. The age group of 50 and 60 years accounted for 28.3%. Forty-six point six percent (46.6%) of our patients were diabetic, 45% obese, 60% hypertensive, 70% sedentary and 10% smokers. Our patients had in 53.3% of cases a blood pressure figure ≥ 130/85 mmHg, abdominal obesity in 100%, hypertriglyceridemia in 33.3%, HDL-C less than 0.40 g/l in 62.5% of men and less than 0.50 g/l in 77.27% of men, blood sugar ≥ 1 g/l in 88.3%. Conclusion: The metabolic syndrome, in view of the entities that compose it, is a real cardiovascular risk factor and therefore a major public health issue.